Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma
The objective is to determine the safety and efficacy of dexosome immunotherapy in patients with Stage IV malignant melanoma
Melanoma
BIOLOGICAL: autologous dexosomes loaded with tumor-specific peptides
The objective is to determine the safety and efficacy of dexosome immunotherapy in patients with Stage IV malignant melanoma